Cargando…

Expression of parafibromin in major renal cell tumors

Parafibromin, encoded by HRPT2 gene, is a recently identified tumor suppressor. Complete and partial loss of its expression have been observed in hyperparathyroidism-jaw tumor (HPT-JT), parathyroid carcinoma, breast carcinoma, lung carcinoma, gastric and colorectal carcinoma. However, little has bee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cui, C., Lal, P., Master, S., Ma, Y., Baradet, T., Bing, Z.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PAGEPress Publications 2012
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3567758/ https://www.ncbi.nlm.nih.gov/pubmed/23361235 http://dx.doi.org/10.4081/ejh.2012.e39

Ejemplares similares

The roles of the tumor suppressor parafibromin in cancer
por: Zheng, Hua-chuan, et al.
Publicado: (2022)

Significance of Parafibromin Expression in Laryngeal Squamous Cell Carcinomas
por: Cho, Inju, et al.
Publicado: (2016)

Parafibromin Abnormalities in Ossifying Fibroma
por: Costa-Guda, Jessica, et al.
Publicado: (2021)

Parafibromin Is Highly Expressed in Hepatocellular Carcinoma and Its Expression Correlates with Poor Prognosis
por: Kim, Min-Kyung
Publicado: (2022)

Parafibromin Staining Characteristics in Urothelial Carcinomas and Relationship with Prognostic Parameters
por: Karaarslan, Serap, et al.
Publicado: (2015)

Diagnostic and prognostic implications of parafibromin immunohistochemistry in parathyroid carcinomaT
por: Pyo, Jung-Soo, et al.
Publicado: (2019)

Downregulated parafibromin expression is a promising marker for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas
por: Zheng, Hua-chuan, et al.
Publicado: (2007)

Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) Parathyroid Tumors Demonstrate Distinctive Morphologic Features
por: Gill, Anthony J., et al.
Publicado: (2019)

Parafibromin governs cell polarity and centrosome assembly in Drosophila neural stem cells
por: Deng, Qiannan, et al.
Publicado: (2022)

Association Between Parafibromin Expression and Presence of Brown Tumors and Jaw Tumors in Patients with Primary Hyperparathyroidism: Series of Cases with Review of the Literature
por: Popow, Michał, et al.
Publicado: (2022)

The parafibromin tumor suppressor protein interacts with actin-binding proteins actinin-2 and actinin-3
por: Agarwal, Sunita K, et al.
Publicado: (2008)

The in vitro and in vivo effects of nuclear and cytosolic parafibromin expression on the aggressive phenotypes of colorectal cancer cells: a search of potential gene therapy target
por: Zheng, Hua-chuan, et al.
Publicado: (2017)

CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer
por: Cetani, Filomena, et al.
Publicado: (2013)

Dephosphorylated parafibromin is a transcriptional coactivator of the Wnt/Hedgehog/Notch pathways
por: Kikuchi, Ippei, et al.
Publicado: (2016)

Characterization of a New CDC73 Missense Mutation that Impairs Parafibromin Expression and Nucleolar Localization
por: Masi, Giulia, et al.
Publicado: (2014)

Parafibromin as a Diagnostic Instrument for Parathyroid Carcinoma-Lone Ranger or Part of the Posse?
por: Juhlin, C. Christofer, et al.
Publicado: (2010)

The tumor suppressor, parafibromin, mediates histone H3 K9 methylation for cyclin D1 repression
por: Yang, Yong-Jin, et al.
Publicado: (2010)

Novel HRPT2/CDC73 Gene Mutations and Loss of Expression of Parafibromin in Chinese Patients with Clinically Sporadic Parathyroid Carcinomas
por: Wang, Ou, et al.
Publicado: (2012)

Decreased expression of calcium-sensing receptor and parafibromin in secondary hyperparathyroidism with an abnormal whole PTH/intact PTH ratio
por: Yamada, Shunsuke, et al.
Publicado: (2013)

Treatment of pathological fractures due to brown tumours in a patient with hyperparathyroidism and lack of parafibromin expression – A case report
por: Wasiak, Michał, et al.
Publicado: (2020)

Transcriptional Co-activator Functions of YAP and TAZ Are Inversely Regulated by Tyrosine Phosphorylation Status of Parafibromin
por: Tang, Chao, et al.
Publicado: (2018)

Transcriptional Co-activator Functions of YAP and TAZ Are Inversely Regulated by Tyrosine Phosphorylation Status of Parafibromin
por: Tang, Chao, et al.
Publicado: (2018)

SAT204 Parafibromin: Key To The Diagnosis Of Atypical Parathyroid Adenoma In A Patient With Suspected Carcinoma
por: Anunobi, Vanessa, et al.
Publicado: (2023)

Major histocompatibility complex I upregulation in clear cell renal cell carcinoma is associated with increased survival
por: Sekar, Rishi R., et al.
Publicado: (2016)

Tumor necrosis factor receptor 2-signaling in CD133-expressing cells in renal clear cell carcinoma
por: Al-Lamki, Rafia S, et al.
Publicado: (2016)

VHL Dependent Expression of REDD1 and PDK3 Proteins in Clear-cell Renal Cell Carcinoma
por: Ilic, Bojana B, et al.
Publicado: (2018)

Prognostic effect of renal collecting system invasion on survival of patients with renal cell carcinoma and tumor thrombus
por: Przydacz, Mikolaj, et al.
Publicado: (2020)

Laparoscopic pancreatectomies for borderline tumors with major venous resections
por: Borys, Maciej, et al.
Publicado: (2022)

A complex RARE is required for the majority of Nedd9 embryonic expression
por: Knutson, Danielle C., et al.
Publicado: (2014)

KRT8 upregulation promotes tumor metastasis and is predictive of a poor prognosis in clear cell renal cell carcinoma
por: Tan, Hai-Song, et al.
Publicado: (2017)

Transplant Radical Nephrectomy and Transplant Radical Nephroureterectomy for Renal Cancer: Postoperative and Survival Outcomes
por: Nabavizadeh, Reza, et al.
Publicado: (2020)

Tumor cell PD-L1 expression is a strong predictor of unfavorable prognosis in immune checkpoint therapy-naive clear cell renal cell cancer
por: Möller, Katharina, et al.
Publicado: (2021)

Preoperative C-reactive protein is related with renal cell tumor dimension? Preliminary results
por: Miron, Adelina, et al.
Publicado: (2022)

Construction and Validation of Protein Expression-related Prognostic Models in Clear Cell Renal Cell Carcinoma
por: Ma, Xuzhan, et al.
Publicado: (2023)

Synergic impact of oral anticoagulation control and renal function in determining major adverse events in atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the AFCAS registry
por: Proietti, Marco, et al.
Publicado: (2017)

Neoadjuvant Nivolumab and Ipilimumab for Nonmetastatic Renal Cell Carcinoma with Tumor Thrombus
por: Master, Viraj A., et al.
Publicado: (2022)

Expression of insulin-like growth factor family genes in clear cell renal cell carcinoma
por: Braczkowski, Ryszard, et al.
Publicado: (2016)

Infiltration of tumor‐associated macrophages is involved in CD44 expression in clear cell renal cell carcinoma
por: Ma, Chaoya, et al.
Publicado: (2016)

Pan-cancer Analysis of NEDD4L and Its Tumor Suppressor Effects in Clear Cell Renal Cell Carcinoma
por: Dong, Huiyue, et al.
Publicado: (2021)

PD-L1 Expression in Clear Cell Renal Cell Carcinoma: An Analysis of Nephrectomy and Sites of Metastases
por: Jilaveanu, L.B., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ta16pou8h6q1ki4dsgsm92s2lh